::: Leader - Responsible for global P&L of the AI & Machine Learning BU through building, partnering, investing, & acquiring digital pathology solutions to advance the frontier in oncology theranostics. Passionate about leading teams in designing, developing, & launching new AI products in the Pharma, Biotech, Payer, & Provider verticals::: Speaker - Invited presenter on topics of unlocking the potential of AI, ML, Computer Vision, & NLP techniques to address unmet clinical needs in oncology::: Researcher - Investigating unleashing the potential of AI to solve challenges in oncology. Focus areas: Tumor Detection, SubTyping, Grading, Biomarker Scoring, & Mutation Prediction ::: Advisor - Tried & trusted relationships with entrepreneurs, executives, KOLs, scientists, & VCsSpecialties: Artificial Intelligence, Machine Learning, Computer Vision, NLP, Deep Learning, Data Science, Modeling, Drug Discovery, Genetic Data, Medical Informatics, FDA Class II Medical Devices, Disease Risk Prediction, Python, Molecular Modeling, Computational Biology, Digital Health, AI in Healthcare, AI Breast Cancer Detection, Oncology , Digital Pathology, Healthcare Strategy, Digital Imaging, AI Product Launch, ISO 13485, Antibody-drug conjugates, Small Molecules, Biologics, Precision Medicine, Multi-omic, Phenotypic Data, Bioinformatics, Target Discovery, Systems Biology, Biomarker Discovery, Digital Diagnostics, AI Lab, Agile Software Development